Athira Pharma, Inc.
Athira Pharma, Inc. (ATHA) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 158 transactions totaling $62.3M, demonstrating a bullish sentiment with $61.9M in net insider flow. The most recent transaction on Jan 2, 2026 involved a sale of 876 shares valued at $6.0K.
ATHA Insider Activity Summary
Who Is Buying ATHA Stock?
No significant insider buying has been recorded for ATHA in the recent period.
Who Is Selling ATHA Stock?
No significant insider selling has been recorded for ATHA in the recent period.
Is Athira Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ATHA is bullish with an Insider Alignment Score of 100/100 and a net flow of $61.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ATHA Frequently Asked Questions
Understanding ATHA Insider Activity
Insider trading at Athira Pharma, Inc. (ATHA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading ATHA stock, having executed 158 transactions in the past 90 days. The most active insider is Joseph Edelman (Executive), who has made 8 transactions totaling $30.6M.
Related Tools
Track Athira Pharma, Inc. Insider Activity
Get notified when executives and directors at ATHA file new Form 4 transactions